Blue Horseshoe Stocks: Review of Friday’s Half-Session & More

Repros Therapeutics, Inc. RPRX

We’re looking at RPRX as a potential momentum-play this morning. After drastically falling off of a precipice at the end of last month, the stock spent several weeks stepping its way down to a new 52-week low. However, in the few sessions since that time RPRX has been making a nice rebound that warrants our putting this play on watch today.

As you can see on the included chart there are a number of bullish signals in effect. There’s also a good bit of real estate between the current PPS and the next area of resistance on the chart, thanks to the stock’s big decline in October. A return to levels prior to that point would mean gains approaching the 100%-mark from here, so we’ll reserve a space on our watchlist for RPRX.


Pleasant Kids, Inc. PLKD  – Options

Since our first mention of this stock back on October 13th, we’ve witnessed one heck of a run from PLKD, with very few setbacks along the way.

We’ve showed the epic move the stock has made using a trendline on the following chart, running from our observed low of .0581 all the way up to the new high registered on Friday. at .279. That’s a mammoth 380% swing, and with the way things have been going for PLKD of late, it would be a mistake for us to let it slip off of our radars at this point.


The Bon-Ton Stores, Inc. BONT

BONT has proved itself to be an immensely successful bottom-call for us over the past week. We re-introduced this past winner on Monday morning, upon which time we would witness the stock trading at a low of 1.25. It proceeded to record four consecutive sessions of higher highs and higher lows throughout last week, just as we’d hoped to see.

BONT’s fantastic recovery carried it to a new high of 2.83 on Friday, which represented an intraweek increase of 126%, congratulations to anyone who made a play on BONT during the short week!


HydroPhi Technologies, Inc. HPTG We’d also like to comment on HPTG, which made an appearance in Friday’s premarket report and ended the short week with a long intraday run from .0027 to .005. It worked out to a 85% spike, and despite being just a half-day, the stock made that move on heavier-than-average volume.


Extended Watchlist:
ARWR, AVXL, CEGX, FROT, LATX,

Blue Horseshoe Stocks: Wrapping Up the Short Week

This holiday-shortened week has brought another string of stellar opportunities for us with both stocks and options, and was an excellent way to close out the first quarter of 2015!



Pazoo, Inc. PZOO

Firstly, our re-alert of PZOO yesterday came just in the nick of time for us to observe a nice upswing. The stock traded up from a low of .0052 to reach .0071, an intraday move of 37% and it did so on more than twice its 30-day average volume.

With the deliberate steps Pazoo has been taking to become actively involved in the cannabis sector, it’s certain to hold our interest for quite awhile. There was a new PR to that effect released after market open yesterday; PZOO’s wholly-owned sub, marijuana testing agency Harris Lee, will be taking full ownership of a “fully functional, revenue generating facility no later than April 30, 2015”. Learn More about Steep Hill @ SteepHillLab.com/colorado

WHIPPANY, N.J., April 1, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#: A1J3DK) is proud to announce that wholly owned subsidiary, Harris Lee, LLC, has entered into a Binding Letter of Intent with Front Range, the Steep Hill licensee for Colorado, to purchase the assets to operate Steep Hill Colorado, a marijuana testing laboratory located in Denver, CO. Additionally, Front Range will transfer all assignable rights and licenses to Harris Lee. >> FULL PR

Visit PZOO @ www.pazoo.com
The new site dedicated to its marijuana testing arm is located @ cannabisking.pazoo.com


Totally Hemp Crazy, Inc. THCZ

Speaking of pot-related plays- Last Friday, we suggested our readers put THCZ on their radars as we were watching the stock search for support. It found it that day at .128, and managed to set higher highs every day since.

Yesterday came an enormous push to an astonishing high of .32; that registered as an overall increase of 150% from THCZ in just five sessions! Even more amazing, is the fact that we observed THCZ trading subpenny as recently as the end of January.


Northstar Global Business Services, Inc. MDIN

MDIN appeared on yesterday’s extended watchlist, and it too enjoyed a nice intraday move of 66%. The stock held the majority of those gains into the close, so we’ll be interested to see how it closes out this short week today.


Pervasip Corp. PVSP

On Monday, we called out PVSP in a well-timed alert that yielded the chance at intraday gains of up to 55% It took until yesterday afternoon for the stock to consolidate and make its way down to find a support level from which to bounce.

That came at .0013, and PVSP did make a nice rebound to the tune of 38% (.0018) This is yet another one which is tied to the cannabis space, so we can definitely see a theme being established here as springtime comes into full-swing.


Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

We signaled May PBR $6 and $6.50 calls last Thursday as we noticed it rebounding off of its newly-established all-time lows. Although there wasn’t much open interest in the May $6 Calls that we highlighted, they were pushed into the money and there was an opportunity to profit for those that decided to take the trade. The low on those contracts was .32 following our alert, and they closed yesterday at .55x.79. With plenty of time left until expiration, we may not yet be finished with them.

There was volume in the May $6.50’s, which traded as low as .22 following our initial mention and yesterday closed at .47; a gain of 114%.


Esperion Therapeutics, Inc. ESPR – Options

It was on Tuesday March 17th that we called ESPR options and came away with percentage gains that ran into the thousands over the course of that week. The idea that we ventured was the 04/17 $90 Calls, and we saw a subsequent run from 3.50 to 28.50.

Following that huge run, we saw those contracts dip back to find support at 4.50 toward the end of last week. Yesterday, a news release helped push ESPR stock to new highs, and as a result the April $90’s went on another big run, up to their closing price of 16.35. That’s a 263% swing in less than a week!

ESPR traded up just shy of $110 in the premarket this morning. We will also want to keep a close eye on the 04/17 $100-110 Calls should the stock continue its upward trend through to next week.


Extended Watchlist:
TXMD, FXCM, RPRX, WBAI, ONVO

Blue Horseshoe Stocks: Recap on RPRX, JNUG, Others

Repros Therapeutics, Inc. RPRX

The primary attraction to come off of our report on Friday was definitely RPRX. The stock had one heck of a solid session, building steadily all day long. It traded from a morning low of 7.66, and reached as high as 10.25 just prior to the close, and did so on volume which exceeded the 3-month average by nearly eight times. That’s a really impressive run from a stock in this price range.

We originally caught RPRX on October 17th after catching the stock gapping down to 52-week lows, and measuring from the low we observed subsequent to that report (5.97), Friday’s high represented an overall increase of 71%

The company is slated to release earnings today >> View Earnings Calendar


Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

Also jumping off of Friday’s extended watchlist with a good showing was JNUG. We seemed to have timed our mention of this ETF quite well, with gold prices having bounced off of their annual low on Thursday, it set the stage for JNUG to make a respectable intraday day for us.

It traded in a range from 3.59-4.44, gaining as much as 24% on considerable volume, to the tune of 4.5X it’s 3-month average.

JNUG could be an interesting play moving forward providing the rebound in the price of gold is sustained, so that will be one of the things we’ll be interested to watch for as we kick off a new trading week.


Dendreon Corp. DNDN

DNDN is taking a massive premarket pounding this morning in the wake of the company’s filing for Chapter 11 protection. It’s worth noting, despite the forthcoming restructuring, the company will continue to produce and distribute its PROVENGE immunotherapy treatment, and has declared that it “has significant liquidity to support all of its operations during the restructuring process, with approximately $100 million of cash, cash equivalents and investments on hand as of November 7, 2014” >> View PR

Because of the nature of the situation, we’ll be exercising extreme caution, but we still want to monitor the stock for a bottom and subsequent bounceplay opportunities that could come as a result.


Extended Watchlist:
ACHN, IBIO, ARQL, DVAX, UEC, OIBR